https://www.selleckchem.com/pr....oducts/nazartinib-eg
There were more differential methylation and expression characteristics between the two predicted groups. The hierarchical clustering analysis showed that the signature could perform better for predicting CIMP status of RCC than current methods. In conclusion, the qualitative transcriptional signature for classifying CIMP status at the individualized level can predict outcome and guide therapy for RCC patients.This study aimed to identify allergic rhinitis (AR)-related hub genes and functionally enriched pathways in a
Like
Comment
Share
